The study of Simmons and colleagues (Simmons et al., 2005) demonstrated that in the SARS-CoV infection, recombinant CatL was sufficient to activate S protein leading to membrane fusion, while the infection was blocked by specific inhibitors of this protease. Here, CTSL is linked to severe acute respiratory syndrome.